Azelis Group N.V.

Azelis Group N.V.

12.19
EUR
-0.58
(-4.54%)
2.26BMarket Cap
Feb 18Next Earn
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
8.96
9.51
12.13
17.65
17.39
17.36
16.97
- -
Basic EPS, GAAP
- -
0.21
0.3
0.29
0.91
0.74
0.74
0.46
- -
Free Cash Flow per Basic Share
- -
0.27
0.45
0.61
1.5
2.12
1.27
1.63
- -
Dividend per Share
- -
- -
- -
- -
0.03
0.28
0.22
0.23
- -
Book Value per Share
5.04
5.28
5.2
9.53
10.2
10.63
11.81
11.07
11.07
Tangible Book Value per Share
-3.77
-4.12
-4.07
-2.48
-4.11
-4.8
-4.32
-4.37
-4.37
Basic Weighted Avg Shares
234
234
234
234
234
240
244
244
244
Sales/Revenue/Turnover
- -
2,095
2,223
2,836
4,125
4,176
4,238
4,132
- -
Operating Margin (%)
- -
6.31
6.62
7.33
9.42
9.27
9.11
7.58
- -
Depreciation Expense
- -
46
51
59
85
101
115
127
- -
Net Income, GAAP
- -
48
71
68
213
178
181
111
- -
Effective Tax Rate (%)
- -
17.61
10.21
41.58
30.44
23.43
26.02
35.28
- -
Profit Margin (%)
- -
2.29
3.19
2.39
5.17
4.26
4.26
2.69
- -
Working Capital
211
230
275
365
469
654
764
677
677
LT Debt
974
1,122
1,191
894
1,260
1,651
1,748
1,737
1,737
Total Equity
1,180
1,235
1,218
2,251
2,440
2,677
2,920
2,716
2,716
Return on Invested Capital (%)
- -
4.57
5.3
4.17
7.51
7.09
6.2
4.33
- -
Return on Capital (%)
- -
4.19
4.98
3.27
6.56
5.78
5.43
3.66
- -
Return on Common Equity (%)
- -
3.98
5.79
3.94
9.24
7.14
6.61
3.99
- -

Capital Structure

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
96
344
137
LT Borrowings
1,614
1,601
1,602
LT Finance Leases
134
121
134
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
244
244
244
Market Capitalization
4,553
3,377
2,261

Working Capital

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
1,583
1,723
1,387
Cash, Cash Equivalents & STI
305
452
263
Accounts Receivable, Net
496
617
440
Inventories
678
644
588
Total Current Liabilities
819
1,029
710
Payables & Accruals
- -
- -
- -
ST Debt
96
344
137
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
21.01%
-7%
Free Cash Flow
- -
43.08%
28.38%
Net Income, GAAP
- -
31.34%
-38.46%
Sales/Revenue/Turnover
- -
14.65%
-2.49%
Total Cash Common Dividend
- -
- -
2.99%

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
4,176
2024
- -
- -
4,238
2025
- -
- -
4,132

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.74
2024
- -
- -
0.74
2025
- -
- -
0.46

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.28
2024
- -
- -
0.22
2025
- -
- -
0.23

Company Description

CEO
Anna Bertona
Full Time Employees
4,189
Sector
Distribution services
Industry
Wholesale distributors
Address
Posthofbrug 12 Antwerp VL Belgium 2600
IPO Date
Sep 17, 2021
Website
azelis.com
Business
Azelis Group NV is a leading global innovation service provider and distributor of specialty chemicals and food ingredients, serving industries including life sciences and industrial chemicals through an integrated network of more than 70 laboratories and technical centers in over 65 countries. Founded in 1996 and headquartered in Antwerp, Belgium, the company operates across Europe, Middle East and Africa, the Americas, and Asia-Pacific, offering products such as surfactants, builders and specialty additives for home care and industrial cleaning; ingredients and formulations for personal care and fragrances; active pharmaceutical ingredients (APIs), finished preparations and veterinary products for pharmaceuticals and healthcare; high-quality ingredients, auxiliary materials and additives for food, nutrition and nutraceuticals; advanced synthesis intermediates for fine chemicals; lubricants and metalworking fluids; high-purity sources, precursors and bonding tools for electronics; crop protection and environmental solutions for agriculture and horticulture; essential chemicals; dyes, pretreatment, bleaching, finishing and coating products for textiles, leather and paper; advanced materials and additives for coatings, adhesives, sealants and elastomers (CASE); and specialized products for animal nutrition and other applications. In recent developments, Azelis has expanded through targeted acquisitions including Distona AG in Switzerland to strengthen industrial chemicals presence in September 2025, Solchem Nature SL in Spain to boost nutraceuticals offerings in July 2025, and S. Amit Group in India to reinforce its footprint; additionally, the company launched its 'Impact 2030' sustainability initiative, expanded partnerships such as with AGRANA for personal care in select Asia-Pacific markets, reported stable FY 2024 profits with improving trends, and achieved a 34% increase in free cash flow for the first nine months of 2025.

Company News

  • Azelis Group NV (AZLGY) Q3 2026 Sales/Trading Call Transcript

  • Azelis Group NV (OTCMKTS:AZLGF) Sees Large Decline in Short Interest

  • Azelis Group NV: Q1 2026 Results: Strong Cash Generation in Volatile Markets

  • Azelis Group NV (AZLGY) Q4 2025 Earnings Call Transcript

  • Azelis: Persistent Margin Pressure Creates Initial Buying Opportunity

  • Azelis Group (OTCMKTS:AZLGF) Trading Down 15.7% – Should You Sell?

  • IMCD And Azelis: Two Specialty Chemical Distributors With Massive Return Potential

  • Azelis Group NV (AZLGY) Q3 2025 Sales Call Transcript

  • Significant Research Activity Led To Six New Positions

  • Azelis: Correction Puts The Stock In The 'Buy' Zone